Skip to main content

Table 6 Hospital stay and cost of the ERAS and control groups

From: Analgesia and patient comfort after enhanced recovery after surgery in uvulopalatopharyngoplasty: a randomised controlled pilot study

 

ERAS Group

(n = 59)

Control Group

(n = 36)

P value

TLOS (days, median(IQR))

8(7–10)

8(7–9)

0.284

PLOS (days, median(IQR))

5(4–7)

4(4–5)

0.340

Total hospitalisation cost (yuan, mean ± SD)

19,478 ± 2570

18,543 ± 2033

0.195

Anaesthetic cost (yuan, mean ± SD)

4028 ± 416

3893 ± 411

0.749

  1. ERAS Enhanced recovery after surgery, TLOS Total length of stay, PLOS Postoperative length of stay, SD Standard deviation